26th annual congress on cancer science and targeting therapies · dear attendees, we are glad to...
TRANSCRIPT
Oct 29-30, 2018 | San Francisco, USA
26th Annual Congress on Cancer Science and Targeting Therapies
Dear Attendees,
We are glad to announce the 26th Annual Congress on Cancer Science and Targeting Therapies to be held in San Francisco, USA from October 29-30, 2018 organized by Conference Series, USA in collaboration with generous support and cooperation from enthusiastic academicians and editorial Board Members.
This conference is a unique international platform that’s a confluence of all Cancer research Industry, Academia, Researchers, Innovators, Regulators – coming together to present and discuss current topics in Target Therapy, Cancer Immunotherapy & Vaccines, Cancer Metabolism, Cancer Inflamation and Immune Tolerance, Nanoparticles in Cancer Therapy, Novel Approaches to Cancer Therapeutics, Cancer Management & Prevention, Cancer Pharmacology, Tumour immunology & immunotherapy, Organ-Specific Cancer, Cancer Biomarkers, Cancer Stem Cell Therapy, Anti-Cancer Agents in Medicinal Chemistry, Cancer Chemotherapy and will be available to discuss with you the latest issues and trends in Overcoming Milestones towards Oncology with the theme “Securing the Future of Innovation in Cancer Treatment”.
As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting edge presentations, special panel discussions and livelier interaction with industry leaders and experts.
Life is full of give and take. Make it count in your professional life. Attend the Cancer Science and Therapy Conference to network with your peers, exchange expertise and experiences and arm yourself with the latest information to take your department to the next level.
We look forward to personally welcoming you to San Francisco, USA
Invitation Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Sincerely,Cancer Therapy 2018
Organizing Committee
Cancer Science and Targeting Therapies 2018 Conference website is attracting 25000+ Oncologists,
Cancer Specialists online visitors ranging from Researchers, Academicians and Business professionals,
who are working in this field. This unique opportunity that we extend to our speakers and attendees is
not being offered by any other conference organizers. Through this the abstracts and research profiles
of our speakers and organizing committee members getting global visibility which is an additional
feature that you would be receiving in addition to networking opportunities before, during and after
the conference.
About Conference
How Conference Series Conferences differs from others?• 3000+ Conferences across the globe in 70+ countries Annually• Over 25 Million+ Visitors and 20000+ Unique Visitors per conference • Participation by Stalwarts from various international societies• Internationally renowned speakers and scientists representation• Career guidance for early career researchers and students • Interesting scientific deliberations and discussions • Perfect platform for Global Networking
Cancer Therapy 2018 salient features • Meet Academia and Industry visionaries to get inspired• Expand your knowledge and find solutions to problems• Knowledge, Benchmarking and Networking offered at one place • Forge connections and for global networking • Highly Organized and Structured Scientific programs• Poster presentations and world class exhibitions • Meet with new vendors and suppliers
Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Purpose26th Annual Congress on Cancer Science and Targeting Therapies is an arena for interdisciplinary exchange among professionals in the fields of Oncology and Cancer Therapy.
GoalsThe conference program emphasizes evidence-based practice, educational innovation, practical application, and peer to peer networking and collaboration. The goals of the conference is to provide a transformative professional development experience through.
• Bringing together the world’s scientific experts to catalyze and advance scientific knowledge about Cancer Science and Therapy present the most recent research findings and promote and enhance scientificcollaborations around the world.
• Bringing together community leaders, scientists and policy leaders to promote and enhance programmatic collaborations to more effectively address regional, national and local responses to Elderly Population around the world and overcome barriers that limit access to care and services.
ObjectivesAfter participating in this meeting, attendees should be able to: • Discuss emerging issues in Oncology• Discuss and apply recent research findings related to Cancer Science and Therapy• Reflect on the place of critical distance in Cancer Science
About Conference Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Who should attend26th Annual Congress on Cancer Science and Targeting Therapies is exclusively designed for Oncologists, Cancer Specialists, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to Cancer Science and Therapy research and treatment.
About hosting organizationConference Series is the world’s leading specialist in organizing Academic, Scientific and Business conferences, meetings, symposiums and exhibitions in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business to promote scientific research. Every year we host more than 3000+ global events inclusive of 1000+ Conferences 1000+ Symposiums 1000+ Workshops in USA, Europe, Middle East and Asia with the generous support and cooperation from our 30000+ Editorial Board Members, 1000+ Scientific Societies. All the conference proceedings are published in the special issues of our 700+ Open Access International Journals with the DOI provided by
• Target Therapy• Cancer Immunotherapy & Vaccines• Cancer Metabolism• Cancer Inflamation and Immune Tolerance • Nanoparticles in Cancer Therapy• Novel Approaches to Cancer Therapeutics• Cancer Management & Prevention• Cancer Pharmacology• Tumour immunology & immunotherapy• Organ-Specific Cancer
• Cancer Biomarkers• Cancer Stem Cell Therapy• Anti-Cancer Agents in Medicinal Chemistry• Surgical Oncology• Cancer: Psychological & Social Aspects• Radiation Oncology• Cancer Chemotherapy• Cancer Diagnostics & Diagnostic Market• Nanoparticles in Cancer Therapy• Etiology of Cancer
Major sessions
About Conference Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Supporting Journals
Media partners/Sponsors
• Journal of Cancer Science & Therapy
• Journal of Carcinogenesis & Mutagenesis
• Journal of Integrative Oncology
About Conference Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Diana AndersonUniversity of Bradford, UK
Leroy J LoweLancaster University,
UK
Yoshiaki OmuraNew York Medical
College, USA
Michael RetskyHarvard TH Chan
School, USA
David Dongliang GeApostle Inc, USA
Frédéric BaribaudJanssen R&D, USA
George VasmatzisMayo Clinic, USA
John Michael SauerCritical Path Institute, USA
Jianhua LuoUniversity of Pittsburgh
School of Medicine, USA
Kamala K MaddaliCancer Genetics Inc.,
USA
Nikolai V IvanovPhilip Morris Research
& Development, Switzerland
Qing Kay LiJohns Hopkins
Medical Institutions, USA
David I SmithMayo Clinic, USA
Sergey SuchkovMoscow State
Medical University, Russia
Srinivas PentyalaStony Brook Medical
Center, USA
San FranciscoUSA
October 29-30 2018
Past Keynote Speakers Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Sherry Bradford AccuTheranostics,
Inc, USA
Sandra S. HatchUniversity of Texas Medical Branch,
USA
Aaron Chevinsky Aurora Health Care,
USA
Elliot M. LevineIllinois Masonic
Medical Center, USA
John S. Davis Olson Center for Women’s Health,
USA
Denise Johnson MillerHackensack
Meridian Health System, USA
Adrian Senderowicz Cerulean Pharma
Inc. USA
Colleen HuberNaturopathic
Oncologist (FNORI), USA
Homer S. Black Baylor College of
Medicine, USA
Hirendra Banerjee Elizabeth City State
University, USA
Jianyu RaoDavid Geffen School of Medicine-UCLA,
USA
Al CharestBeth Israel
Deaconess Medical Center, USA
David ChafinRoche Tissue
Diagnostics, USA
Andrea NicoliniUniversity of Pisa,
Italy
G Mike MakrigiorgosHarvard Medical
School, USA
San FranciscoUSA
October 29-30 2018
Past Keynote Speakers Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Jianhua LuoUniversity of
Pittsburgh, USA
David I SmithMayo Clinic, USA
Nabeela ShamiLahore Medical
and Dental College, Pakistan
James McNamaraUniversity of Iowa,
USA
Shaila Anwar Ghurki Trust
Teaching Hospital, Pakistan
San FranciscoUSA
October 29-30 2018
Past Moderators Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018 Glimpses
Paul J. Davis, MD Professor of Medicine, Albany Medical College, USA Professor of Pharmacology, Albany College of Pharmacy and Health Sciences, USA
The recent Stem Cell Congress in Chicago was, from the scientific standpoint, the highest quality and most useful of the three OMICS-sponsored conferences that I have attended. The presentations I heard were uniformly good.
I’d be pleased to see such meetings have a larger audience.
Simon BerkovichThe George Washington University,USA
I have received very positive feedback from Chen Shen who presented our work in Chicago and got in contact with many different people interested in our research.
Diana AndersonUniversity of Bradford, UK
I just want to say how much I enjoyed the meeting in Chicago. I always find the meetings extremely stimulating and very interactive. The quality of the presentations is very good and some of them are very thought-provoking.
In general, all your meetings I attend are of high quality, I hope to come to Philadelphia next year.Zhenyi HuoBestStem Biotech
It was a great opportunity to meet scientists, scholars and research workers in the cellular field in Chicago last week. And also I would particularly thank you for your effort to list Best Stem Biotech as one of the supporting partners for the 5th World Congress on Cell & Stem Cell Research.
I do hope we could work as partners for future events organized by Conference Series and also explore the possibility to organize the similar events in regenerative medicines in China some day. Probably, at the convenience of your executives/managers, I would like to pay a visit with them.
Christian DrapeauChief Scientific Officer, Stemtech International, Inc.
From what I have seen, the organization was very good. I am always impressed by the quality of presenters and the opportunity for contacts that can be made at the OMICS conferences.
Thank you for your support,
San FranciscoUSA
October 29-30 2018
Speakers Testimonials Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
San Francisco, in northern California, is a hilly city on the tip of a peninsula surrounded by the Pacific Ocean and San Francisco Bay. It’s known for its year-round fog, iconic Golden Gate Bridge, cable cars and colorful Victorian houses. The Financial District’s Transamerica Pyramid is its most distinctive skyscraper. In the bay sits Alcatraz Island, site of the notorious former prison. This is the place to find out about all things San Francisco.
San Francisco may only stretch across 7 miles, but it’s packed with an assortment of activities that’s sure to please outdoorsy types, foodies and curious wanderers of all ages. The Golden Gate Bridge is a must-see, while a visit to Alcatraz Island to tour the infamous and now closed federal prison should also be high on your list. And whether it’s climbing to the top of Twin Peaks or sauntering through Golden Gate Park, active types and nature lovers will find plenty to love about San Francisco.
Cancer research in San Francisco:UCSF’s long tradition of excellence in cancer research includes, notably, the Nobel Prize-winning work of J. Michael Bishop, MD, and Harold Varmus, MD, who discovered cancer-causing oncogenes. Any cancer center can call itself comprehensive, but the UCSF Helen Diller Family Comprehensive Cancer Center has earned that designation from the National Cancer Institute (NCI). “Comprehensive” signifies demonstrated national leadership in laboratory, clinical and population-based research activities with substantial transdisciplinary research that bridges these scientific areas.The excellence of the Cancer Center is widely recognized. It consistently ranks among the top 10 medical centers in the nation for cancer care, according to annual best hospitals surveys from US News & World Report
About San Francisco Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Venue & Accommodation
San Francisco, USATo be announced soon
Contact us
Annie DiazProgram Director | Cancer Therapy 2018Kemp House, 152 City Road, London EC1V 2NXW: http://cancer.global-summit.com/america/E: [email protected]
Tel: +1-888-843-8169; Fax: +1-650-618-1417
Contact Us Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018
Academic
Only Registration: USD 699 Package A (Registration + 2 nights’ Accommodation): USD 1099 Package B (Registration + 3 nights’ Accommodation): USD 1199
Business
Only Registration: USD 799Package A (Registration + 2 nights’ Accommodation): USD 1199Package B (Registration + 3 nights’ Accommodation): USD 1299
StudentStudent Oral: USD 399Student Poster: USD 399 (USD 399 + USD 100 for Poster)
Student Delegate: USD 299
E-poster: USD 99
Important Dates
Abstract submission opens: November 01, 2017Registration opens: November 15, 2017Early bird registration: January 31, 2018On spot registration: October 29, 2018
About Registration
To register online, please visit: http://cancer.global-summit.com/america/registration.php
Cancer Therapy 2018
San FranciscoUSA
October 29-30 2018